Adimmune Corporation

Short Term Long Term Short Term Comparison Long Term Comparison
  • 4142
  • 1d-1.51%
  • 1w-0.57%
  • 1m-1.32%
  • 1y-35.35%
ATH
  • ATH Price$77.19
  • ATH Date2020-09-08
  • % since ATH-66.12%
  • % to ATH195.18%
ATL
  • ATL Price$15.16
  • ATL Date2015-08-25
  • % from ATL72.49%
  • Last Low Price$26.3
  • Last Low Date2024-04-08
  • % From Last Low-0.57%
IPO
  • IPO Price$66.36
  • % Current ROI USD-60.59%
  • ATH Price$77.19
  • % ROI ATH 50,915.02%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="4142"]

Key Data [addtoany]

Current price $26.15
Sector Healthcare
Industry Biotechnology
Today's High/Low $26.55/$26.1
Volume 559,858.00
Previous Close $26.55
52 Week High/Low $41.25/$26.2
Market Cap 11,191,036,928.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$26.15
[addtoany]

Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, an influenza vaccine; tetanus toxoid alum precipitated products used for prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent and Tetravalent influenza vaccines; Influenza A (H1N1) virus monovalent vaccines; and Tuberculin, as well as contract manufacturing services.
The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan.

Annual Data | Millions of US $ except per share data 2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Cash on hand -----------
Receivables $505.05$437.91$41.84$402.23$22.75$206.53$170.62$88.53$26.77$110.79$307.23
Inventory $427.90$490.63$637.94$507.96$493.80$372.13$305.38$167.96$189.24$247.72$262.40
Pre-Paid Expenses -----------
Other Current Assets $139.42$66.73$45.73$82.28$26.33$73.43$70.39$78.52$79.68$51.97$38.68
Total Current Assets $2,339.96$1,724.48$2,037.42$2,727.01$1,545.18$1,669.03$1,046.44----
Property, Plant, And Equipment $2,315.42$2,450.72$2,606.04$2,768.88$2,986.61$3,214.52$3,428.84$3,640.91$3,480.38$3,281$3,218.64
Long-Term Investments -$207.48$136.82$165.51$154.08$119.16$97.35----
Goodwill And Intangible Assets -----------
Other Long-Term Assets $1,642.96$1,178.77$843.02$847$445.29$521.61$535.93$263.35$185.14$67.71$85.41
Total Long-Term Assets $4,230.34$3,953.76$3,708.44$4,057.86-------
Total Assets $6,570.30$5,678.24$5,745.86$6,784.87$5,434.54$5,857.05$5,486.50$5,993.41$5,608.28$5,417.07$5,708.58
Total Current Liabilities $209.66$1,204.65$610.80$818.23$428.41$202.82$396.95$325.99$275.47$353.42$801.11
Long Term Debt $2,531.02$2,613.16$2,724.22$2,808.95$1,300$1,180.27$1,843.42$1,920.92$1,734.47$1,000.47$1,137
Other Non-Current Liabilities $3.78$4.15$61.50$62.79$21.22$6.57$8.18$3.72$0.05$0.74$3.76
Total Long Term Liabilities $2,534.97$2,617.30$2,785.72$2,871.74-------
Total Liabilities $2,744.63$3,821.95$3,396.51$3,689.97$1,749.63$1,389.66$2,249.42$2,250.64$2,009.98$1,354.62$1,941.87
Common Stock Net $3,631.58$2,377.43$2,376.84$2,376.13$2,376.13$2,374.83$1,858.36$1,841.52$1,643.77$1,638.38$1,583.10
Retained Earnings (Accumulated Deficit) $-1,225.60$-929.23$-760.31$-595.81$-762.29$-613.13$-613.42-$156.17$643.62-
Comprehensive Income -----------
Other Share Holders Equity $102.74$138.43$67.77$96.46$82.95$48.03$13.43----
Share Holder Equity $3,645.34$1,642.78$2,109.76$2,878.54$3,436.34$4,197.60$3,237.08$3,742.77$3,598.29$4,062.44$3,766.71
Total Liabilities And Share Holders Equity -----------